As a leading manufacturer and supplier of medical diagnostic products in China, Hangzhou Testsea Biotechnology Co., Ltd. is proud to introduce our latest innovation - the Triple Cardiac Marker Test. This rapid cardiac panel test kit is designed to provide quick and accurate results for the detection of myoglobin, CK-MB, and Troponin I, three crucial biomarkers for diagnosing heart attacks. Our IVD cardiac test immuno assay is user-friendly and delivers reliable results, making it an essential tool for healthcare professionals in the management of cardiac patients. The combo test is a highly sensitive and specific method for the early diagnosis of acute myocardial infarction, allowing for prompt intervention and improved patient outcomes. At Hangzhou Testsea, we are committed to developing advanced diagnostic solutions to meet the evolving needs of the medical community. With our Triple Cardiac Marker Test, healthcare providers can now efficiently assess cardiac damage and make informed treatment decisions, ultimately contributing to better patient care. Contact us to learn more about our comprehensive range of cardiac tests and diagnostic tools.
